Saab’s Results January-June 2016 Defence and security

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Saab’s Results January-June 2016

Defence and security company Saab presents the results for January-June 2016. Statement by the President and CEO Håkan Buskhe: Market development Growing turmoil around the world is impacting the defence market. As a consequence of constrained budgets, Saab is seeing an increase in short-term demand for defence capabilities with cost efficient products and solutions. This makes our efforts with efficiency and to reduce lead times more important than ever. Saab’s focus is partly to take advantage of market opportunities and partly on the execution of a number of major projects. Strong growth in order bookings During the first half-year 2016, Saab was awarded a number of new contracts, including for airborne surveillance, ammunition for the Carl-Gustaf weapon system, and the development and production of the New Lightweight Torpedo system for Sweden. Order bookings amounted to MSEK 11,462, compared to MSEK 18,996 in the previous year. An order from the Swedish Defence Material Administration (FMV) for Type A26 submarines was booked during the first half-year 2015, as was the overhaul and upgrade of Gotland-class submarines, together valued at SEK 8.6 billion. The order backlog at the end of the period was MSEK 111,593. Gripen E offers increased defence capabilities The Gripen E was rolled out on May 18. Users of Gripen E can operate longer in the air, improved sensors and electronic warfare will provide better intelligence on the enemy, and it will carry more and better weapons. At the same time, Gripen E is highly cost-efficient. Deliveries of the next-generation Gripen to Sweden and Brazil will begin in 2019. Sales growth Sales amounted to MSEK 13,854 in the first half-year, an increase of 22 per cent. All business areas improved their sales during the period. The increase was mainly due to the Gripen programme in the business area Aeronautics, a 2015 order for a new version of an airborne surveillance system, GlobalEye, in the business areas Surveillance and Support and Services, and the development of the A26 submarine in the business unit Saab Kockums. Operating income amounted to MSEK 611 (367) in the first half-year and the operating margin was 4.4 per cent (3.2). All business areas but Industrial Products and Services and the business unit Saab Kockums improved their operating margins. Business area Dynamics saw the biggest improvement in operating income thanks to increased deliveries and a change in the product mix. Operating income was again affected by investments in the development of a new jet trainer together with Boeing (the T-X program), as well as by several major projects in early stages where they normally generate lower profit. Strong cash flow Operational cash flow amounted to MSEK 4,193 (-1,806) in the first half-year. Cash flow strengthened in several areas. The increase is mainly related to large payments within the framework of orders for Gripen and an order for GlobalEye. Net debt amounted to MSEK 405 at the end of the period, compared to MSEK 3,217 at the end of 2015. Unchanged outlook statement 2016: ·  In 2016, we estimate sales to be in line with Saab’s long-term financial goal: annual organic sales growth of 5 per cent. ·  The operating margin 2016, excluding material non-recurring items, is expected to be in line with 2015. Financial highlights MSEK  Jan-Jun Jan Change, Q2 Q2 Full 2016  -Jun %  2016  2015  Year 2015  2015 Order bookings 11,462 18,996 -40 6,848 14,196 81,175 Order backlog 111,593 67,853 64 113,834 Sales 13,854 11,329 22 7,064 5,940 27,186 Gross income 3,080 2,674 15 1,569 1,358 6,486 Gross margin, % 22.2 23.6  22.2 22.9 23.9 EBITDA  1,075  830  30  551  392  2,859 EBITDA margin, %  7.8  7.3  7.8  6.6  10.5 Operating income (EBIT) 611 367 66 317 157 1,900 Operating margin, % 4.4 3.2 4.5 2.6 7.0 Net income 414 257 61 191 167 1,402 Earnings per share 3.71 2.21 1.71 1.42 12.79 after dilution, SEK Return on equity, % 13.0 8.6 11.5 Operational cash flow 4,193 -1,806 1,137 -1,001 -500 Free cash flow 4,051 -2,082 1,096 -1,141 -726 Free cash flow per 37.91 -19.57 10.25 -10.72 -6.82 share   after dilution, SEK For more information and explanations regarding the usage of these key ratios, please see http://saabgroup.com/investor-relations/finan...ey-ratios/ . Press and analyst meeting Saab invites to a press and analyst meeting, where CEO Håkan Buskhe and CFO Magnus Örnberg present the Saab January-June interim report 2015. Date: Thursday, 21 July at 10:00 (CET) Address: Grand Hôtel, Blasieholmshamnen 8, Stockholm, Sweden Venue: New York You are welcome to participate on site at Grand Hôtel, watch the live webcast or dial in to the conference call. It is possible to post questions also over the web and conference call. Live webcast: http://saab-interimreport.creo.se/160721 Conference call: Please, dial in using one of the numbers below. UK: +44 2030089813 US: +1 8557532235 SE: +46 856642700 The interim report, the presentation material and the webcast will be available on http://www.saabgroup.com/en/InvestorRelations. R.S.V.P E-mail: marie.bergstrom@saabgroup.com Tel: +46 8 463 02 45 For further information, please contact: Saab Press Centre, +46 (0)734 180 018, presscentre@saabgroup.com Saab Investor Relations, Ann-Sofi Jönsson, +46 (0) 734 187 214 www.saabgroup.com www.saabgroup.com/YouTube Follow us on Twitter: @saab Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. This information is such that Saab AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, on 17 July 2015 at 07.30 (CET).

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 307

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 211

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 246

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 694

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 351

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 239

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 27

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 180

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

HD Hyundai Sparks Fusion Hopes with ITER Milestone

Updated Category News Views 9

Hold on to Your Hard Hats, Fusion Milestone Achieved Look who's making waves in the world of nuclear fusion. HD Hyundai Heavy Industries has hit a crucial benchmark in the ITER nuclear fusion project. This ain't your run-of-the-mill accomplishment, folks. We're talking about completing the assembly of some of the most complex and intricately designed machinery known to...

Continue Reading
ChemoMetec Boosts Financial Outlook with Anticipated Growth

Updated Category News Views 353

ChemoMetec Boosts Financial Outlook Amid Growing Interest ChemoMetec is excited to announce an upgrade in its financial guidance as the company sees a growing demand for its pioneering technologies, particularly the highly regarded XcytoMatic platform. This surge in interest bodes well for the company's revenue and profit, reflecting a positive trajectory as it approaches...

Continue Reading
GDS Holdings Completes Successful C-REIT IPO on Shanghai Exchange

Updated Category News Views 200

GDS Holdings Limited Celebrates C-REIT IPO Success GDS Holdings Limited, known as GDS, is thrilled to announce that it has successfully completed its initial public offering of its China REIT, or C-REIT, on the Shanghai Stock Exchange. This milestone marks an exciting moment for the company and its stakeholders as market interest surpassed expectations. Highlighting the...

Continue Reading
Innovative E-Waste Solutions from Techbros Redefine Recycling

Updated Category News Views 273

AI-Driven E-Waste Innovation from Techbros In a remarkable leap towards sustainability and innovative technology, Techbros Electronic Recycling proudly announces the launch of the Southwest's first fully integrated AI-driven IT asset disposition (ITAD) and e-waste processing facility. This state-of-the-art facility exemplifies the future of electronics recycling by...

Continue Reading
SageSure Welcomes Insurance Veteran Peter Hearn to Board

Updated Category News Views 268

SageSure Welcomes New Board Member SageSure, one of the largest managing general underwriters that focus on markets exposed to catastrophe risks, has taken a significant step by appointing Peter Hearn to its Board of Managers. This strategic move is anticipated to bolster the company’s leadership and industry insights. Peter Hearn's Impressive Background Peter Hearn...

Continue Reading